World's 1st trial of drug developed from iPS cells to begin


The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.


©2023 GPlusMedia Inc.

Login to comment

why start with rare diseases? fop hardly seems like a disease that warrants such important research.

-4 ( +0 / -4 )

@nakanoguy04 Not to the people who have it.

3 ( +3 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites